Sign in to view content

Therapeutic Horizons for Dry AMD

Robert L. Avery, MD

Video
Published 2019

Related

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD
Annual Meeting Talks
2022
Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
Annual Meeting Talks
2021
Progression of Visual Function Endpoints in Early and Intermediate Age-Related Macular Degeneration
Eleonora Lad, MD, PhD
Annual Meeting Talks
2018

Category: AMD-Non-Neovascular

See more